| Document Date: 2014-11-17 11:50:27
Open Document File Size: 425,24 KBShare Result on Facebook
City Reference / / Company Reckitt Benckiser Pharmaceuticals Inc. / / Event Product Recall / Product Issues / / Facility Store SUBOXONE / / IndustryTerm hazardous machinery / buprenorphine products / Healthcare professionals / administered product / buprenorphineͲcontaining product / buprenorphineͲonly products / buprenorphineͲcontaining products / drug products / buprenorphine product / / MedicalCondition insomnia / glossodynia / oral mucosal erythema / oral hypoesthesia / headache / nausea / hyperhidrosis / pain / vomiting / fatal / respiratory depression / withdrawal syndrome / respiratory depression / Hypersensitivity / opioid withdrawal syndrome / withdrawal symptoms / constipation / / MedicalTreatment behavioral therapy / counseling / / MusicGroup I.D. / / Organization Chronic administration / FDA / / Position counsel / / Product naloxone / SUBOXONE / syndrome / signs / Zubsolv tablets / naloxone HCl / SUBUTEX / Neonatal / Naloxone hydrochloride / patients with moderate hepatic impairment / machinery / / PublishedMedium the Medication Guide / / URL www.SuboxoneFilmREMS.com / www.fda.gov/medwatch/report.htm / /
SocialTag |
OfficeͲBasedBuprenorphine TherapyforOpioid Dependence: ImportantInformationfor Prescribers